Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Enter your email address below and subscribe to our newsletter

Regenxbio Inc. announced the publication of their phase 1/2a study results in The Lancet, showcasing the effectiveness of ABBV-RGX-314 as a one-time gene therapy for wet age-related macular degeneration (AMD). Lancet Study Highlights Safety and Efficacy of ABBV-RGX-314 The study,…

Provectus Biopharmaceuticals, Inc. has signed an exclusive global licensing agreement with the University of Miami. This partnership aims to harness the University’s pioneering photodynamic antimicrobial therapy (PDAT) for combating bacterial, fungal, and parasitic (acanthamoeba) eye infections. Launching a Start-Up for…

A recent study has introduced an innovative approach to treating retinal detachment through an artificial vitreous body made from alginate, a natural carbohydrate extracted from algae. This research represents a collaboration among experts from Pohang University of Science and Technology…
In a review published in MedComm – Future Medicine, a research team led by Gao Yuanxu from Macau University of Science and Technology, with Miao Hanpei of Southern Medical University as the first author, sheds light on the promising intersection…

Scientists at the University of Waterloo have made a groundbreaking development in eye care technology by creating a new type of contact lens that not only serves as a protective bandage for corneal wounds but also delivers healing drugs in…

Research teams at Purdue University’s College of Engineering have been awarded two grants from the National Eye Institute, totaling an impressive $6.7 million. These funds are earmarked for the development of specialized smart soft contact lenses designed for the continuous monitoring…

As we bid farewell to 2023, it’s time to reflect on the remarkable collaborations that have shaped the landscape of ophthalmic innovation. The past year witnessed groundbreaking partnerships between pharmaceutical giants, tech innovators, and research institutions, all aimed at advancing…

In a groundbreaking era of medical research, scientists and clinicians are spearheading novel gene therapies that hold promise for transforming the landscape of eye disease treatment. These cutting-edge interventions address a spectrum of conditions ranging from Usher Syndrome and retinoschisis…

In a groundbreaking year for ophthalmic advancements, 2023 has witnessed the launch of cutting-edge medical devices that promise to reshape the landscape of eye care. From augmented reality headsets to innovative surgical systems, the field is experiencing a wave of…

In a study published in JAMA Ophthalmology, researchers from Oregon Health & Science University (OHSU) alongside international collaborators have unveiled an artificial intelligence (AI) technology capable of independently detecting all severe cases of a condition leading to blindness in prematurely…